title: Best practices: implementation of a glucose screening program based on diffusion of innovation theory methods.
abstract: There is public health interest in the identification and treatment of modifiable cardiometabolic risk factors among patients treated with antipsychotic medications. However, best-practice screening recommendations endorsed by multiple medical organizations have not translated into real-world clinical practice. Quality improvement strategies may help to address the gap between policy and implementation. This column describes the successful implementation of a best-practice glucose screening program in a large network of community mental health centers that was based on Six Sigma and diffusion of innovation theory.
authors.affiliation: Department of Psychiatry, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8134, St. Louis, MO 63110, USA. nicolg@wustl.edu
authors.forename: Ginger E
authors.initials: GE
authors.lastname: Nicol
authors.forename: Elaine H
authors.initials: EH
authors.lastname: Morrato
authors.forename: Mark C
authors.initials: MC
authors.lastname: Johnson
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Campagna
authors.forename: Michael D
authors.initials: MD
authors.lastname: Yingling
authors.forename: Victor
authors.initials: V
authors.lastname: Pham
authors.forename: John W
authors.initials: JW
authors.lastname: Newcomer
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D019985:Benchmarking; D001786:Blood Glucose; D003156:Community Mental Health Services; D019058:Community Networks; D004059:Diffusion of Innovation; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced / Q000517:prevention & control*; D008403:Mass Screening; D058996:Quality Improvement; D014481:United States
chemical_list: D014150:Antipsychotic Agents; D001786:Blood Glucose